THERAPIE DE LA MALADIE D'ALZHEIMER A BASE DE BACLOFENE ET D'ACAMPROSATE CHEZ DES PATIENTS AYANT PERDU LA SENSIBILITE A UNE THERAPIE PAR UN INHIBITEUR DE L'ACETYLCHOLINESTERASE
The present invention relates to combinations and methods based on Baclofen and Acamprosate for the treatment of Alzheimer's disease or Alzheimer's related disorders in patients who do not respond to an inhibitor of acetylcholinesterase, typically in patients treated with an inhibitor of acetylcholinesterase and who have lost responsiveness to said 5 inhibitor of acetylcholinesterase.